The company has a great miniature 3D endoscopic microscope, the product of years of development by very clever people. But it is a new tool for specialised purposes and it will take some time to let potential customers know about it and advance the applications. The company cannot just go down to the bus station and hand out leaflets and hope for sales. They are dependent on the contracts that were made under previous management for sales. You conveniently overlooked the fact that they are expecting sales to pick up in the next year. And they deserve credit for not just standing still but trying to showcase potential uses through trials.
What else would you have them do?
Ann: OptiScan March 2019 Presentation, page-8
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.5¢ | $8.406K | 53.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 36100 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 2467 | 1 |
View Market Depth
| Last trade - 10.28am 26/11/2024 (20 minute delay) ? |
| OIL (ASX) Chart |
